Acquisition Channel Expansion Following the Feb 2026 acquisition by SSI Diagnostica Group, InDevR gains access to SSI's global sales channels and installed base in infectious disease testing. This creates rapid cross-sell opportunities for InDevR's multiplexed vaccine analytics and QC kits to existing SSI customers. Recommend joint GTM plans, bundled offerings around VaxArray and OmniFlu HA, and channel-enabled pricing to accelerate revenue.

Strategic Partnerships Network InDevR's 2025 Aldevron collaboration and 2024 Sino Biological partnership indicate strong alignment with ecosystem partners in vaccine development and cell/gene therapy. This opens doors to co-sell analytics for mRNA/VLPs, CGT products, and in-process testing. Propose targeted outreach to these partner networks to introduce integrated analytics solutions.

Multiplexed QC Portfolio Product portfolio demonstrates ready-to-use, multiplexed QC tools for vaccine manufacturing, such as OmniFlu HA and VaxArray Pneumococcal Assay Kit. The market trend favors standardization and automation to speed development and QC. Opportunity to upsell to existing customers and to CROs/CMOs needing validated kits, plus plans for expansion into mRNA and CGT QC panels.

mRNA CGT Focus Market signals show growing focus on mRNA and CGT analytics, evidenced by Aldevron and Sino Biological collaborations. InDevR is well positioned to offer multiplexed assays that measure RNA integrity, antigen content, and QC in complex biologics. Target biotech firms working on mRNA vaccines, gene therapies, and viral vectors with bundled or integrated analytics packages.

Global Reach With a small, agile team (11-50 employees) and revenue in the 10-25M range, InDevR can scale rapidly through channel partnerships and enterprise agreements. The global customer base includes leading pharma and research institutions, providing a ready market for expanded service levels, multi-region support, and long-term QA contracts. Consider offering global managed services and partner-driven sales to maximize reach.